CN102041317A - 基于g4dna酶显色的可视化基因鉴别检测试剂的制备方法 - Google Patents
基于g4dna酶显色的可视化基因鉴别检测试剂的制备方法 Download PDFInfo
- Publication number
- CN102041317A CN102041317A CN 201010555428 CN201010555428A CN102041317A CN 102041317 A CN102041317 A CN 102041317A CN 201010555428 CN201010555428 CN 201010555428 CN 201010555428 A CN201010555428 A CN 201010555428A CN 102041317 A CN102041317 A CN 102041317A
- Authority
- CN
- China
- Prior art keywords
- sequence
- dna
- detection reagent
- dna enzyme
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 40
- 238000001514 detection method Methods 0.000 title claims abstract description 38
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 21
- 230000000007 visual effect Effects 0.000 title claims abstract description 18
- 238000000034 method Methods 0.000 title abstract description 14
- 239000000523 sample Substances 0.000 claims abstract description 46
- 238000006243 chemical reaction Methods 0.000 claims abstract description 37
- 238000007846 asymmetric PCR Methods 0.000 claims abstract description 20
- 239000002299 complementary DNA Substances 0.000 claims abstract description 20
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 13
- 238000000137 annealing Methods 0.000 claims abstract description 10
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 claims abstract description 9
- 230000002860 competitive effect Effects 0.000 claims abstract description 8
- 229940025294 hemin Drugs 0.000 claims abstract description 8
- 238000010839 reverse transcription Methods 0.000 claims abstract description 8
- 241000710777 Classical swine fever virus Species 0.000 claims abstract description 6
- 241000713869 Moloney murine leukemia virus Species 0.000 claims abstract description 5
- 230000003321 amplification Effects 0.000 claims abstract description 5
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 5
- 238000010257 thawing Methods 0.000 claims abstract description 4
- 238000000605 extraction Methods 0.000 claims abstract description 3
- 108020004414 DNA Proteins 0.000 claims description 60
- 102000004190 Enzymes Human genes 0.000 claims description 39
- 108090000790 Enzymes Proteins 0.000 claims description 39
- 238000002360 preparation method Methods 0.000 claims description 20
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 13
- 230000008859 change Effects 0.000 claims description 12
- 238000013016 damping Methods 0.000 claims description 12
- 239000012530 fluid Substances 0.000 claims description 12
- 230000002441 reversible effect Effects 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000012154 double-distilled water Substances 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 9
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 8
- 238000012360 testing method Methods 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 230000009385 viral infection Effects 0.000 claims description 4
- 101710200526 DNA polymerase 2 Proteins 0.000 claims description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 3
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 3
- 230000001351 cycling effect Effects 0.000 claims description 3
- 239000002532 enzyme inhibitor Substances 0.000 claims description 3
- DBLXOVFQHHSKRC-UHFFFAOYSA-N ethanesulfonic acid;2-piperazin-1-ylethanol Chemical compound CCS(O)(=O)=O.OCCN1CCNCC1 DBLXOVFQHHSKRC-UHFFFAOYSA-N 0.000 claims description 3
- 239000006166 lysate Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 108091092562 ribozyme Proteins 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- 230000002103 transcriptional effect Effects 0.000 claims description 3
- 229960005486 vaccine Drugs 0.000 abstract description 18
- 241000700605 Viruses Species 0.000 abstract description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract description 7
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000007850 degeneration Effects 0.000 abstract 2
- 238000003752 polymerase chain reaction Methods 0.000 abstract 2
- 102100034343 Integrase Human genes 0.000 abstract 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 abstract 1
- 230000002779 inactivation Effects 0.000 abstract 1
- 230000002934 lysing effect Effects 0.000 abstract 1
- 239000011535 reaction buffer Substances 0.000 abstract 1
- 241000282898 Sus scrofa Species 0.000 description 33
- 206010037660 Pyrexia Diseases 0.000 description 29
- 239000002574 poison Substances 0.000 description 23
- 231100000614 poison Toxicity 0.000 description 23
- 102000003992 Peroxidases Human genes 0.000 description 12
- 108040007629 peroxidase activity proteins Proteins 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- 150000007523 nucleic acids Chemical class 0.000 description 9
- 241000710778 Pestivirus Species 0.000 description 8
- 108020004707 nucleic acids Proteins 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 description 7
- 230000035772 mutation Effects 0.000 description 7
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 5
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 5
- 238000006555 catalytic reaction Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 2
- IITIZHOBOIBGBW-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole Chemical compound C1=CC=C2N(CC)CSC2=C1 IITIZHOBOIBGBW-UHFFFAOYSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000001726 Classical Swine Fever Diseases 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 101710091045 Envelope protein Proteins 0.000 description 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 108010078851 HIV Reverse Transcriptase Proteins 0.000 description 1
- 102100034349 Integrase Human genes 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 230000010748 Photoabsorption Effects 0.000 description 1
- 101710188315 Protein X Proteins 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 108091027569 Z-DNA Proteins 0.000 description 1
- USYLIGCRWXYYPZ-UHFFFAOYSA-N [Cl].[Fe] Chemical compound [Cl].[Fe] USYLIGCRWXYYPZ-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 239000000549 coloured material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000022602 disease susceptibility Diseases 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000000105 evaporative light scattering detection Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010555428 CN102041317B (zh) | 2010-11-23 | 2010-11-23 | 检测猪瘟病毒的试剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010555428 CN102041317B (zh) | 2010-11-23 | 2010-11-23 | 检测猪瘟病毒的试剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102041317A true CN102041317A (zh) | 2011-05-04 |
CN102041317B CN102041317B (zh) | 2013-07-10 |
Family
ID=43907865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010555428 Active CN102041317B (zh) | 2010-11-23 | 2010-11-23 | 检测猪瘟病毒的试剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102041317B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102628085A (zh) * | 2012-04-24 | 2012-08-08 | 武汉大学 | 结核分枝杆菌利福平耐药突变可视化检测探针及其应用 |
CN102732610A (zh) * | 2012-03-23 | 2012-10-17 | 章晓联 | 可视化检测探针及在结核病利福平耐药突变检测中的应用 |
CN104611462A (zh) * | 2014-12-09 | 2015-05-13 | 贵州大兴农业科技发展有限公司 | 一种基于g-四链体荧光特性的猪瘟病毒检测方法及试剂盒 |
CN110452965A (zh) * | 2019-05-28 | 2019-11-15 | 临沂大学 | 基于重组酶扩增和g-四连体的层出镰刀菌目视检测方法 |
CN112048547A (zh) * | 2019-06-06 | 2020-12-08 | 同济大学 | 一种脊肌萎缩症致病基因检测试剂盒及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6562570B1 (en) * | 1999-04-02 | 2003-05-13 | City Of Hope | Method for identifying accessible binding sites on RNA |
CN101985665A (zh) * | 2010-11-12 | 2011-03-16 | 复旦大学 | 一种检测多种呼吸道病毒的方法及其引物与探针 |
-
2010
- 2010-11-23 CN CN 201010555428 patent/CN102041317B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6562570B1 (en) * | 1999-04-02 | 2003-05-13 | City Of Hope | Method for identifying accessible binding sites on RNA |
CN101985665A (zh) * | 2010-11-12 | 2011-03-16 | 复旦大学 | 一种检测多种呼吸道病毒的方法及其引物与探针 |
Non-Patent Citations (1)
Title |
---|
《J Am Chem》 20080903 Ddeng M,et al 《Highly Effective Colorimetric and Visual Detection of Nucleic Acids Using an Asymmetrically Split Peroxidase DNAzyme》 13095-102 1-10 第130卷, 第39期 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102732610A (zh) * | 2012-03-23 | 2012-10-17 | 章晓联 | 可视化检测探针及在结核病利福平耐药突变检测中的应用 |
CN102628085A (zh) * | 2012-04-24 | 2012-08-08 | 武汉大学 | 结核分枝杆菌利福平耐药突变可视化检测探针及其应用 |
CN104611462A (zh) * | 2014-12-09 | 2015-05-13 | 贵州大兴农业科技发展有限公司 | 一种基于g-四链体荧光特性的猪瘟病毒检测方法及试剂盒 |
CN104611462B (zh) * | 2014-12-09 | 2017-12-29 | 贵州大兴农业科技发展有限公司 | 一种基于g‑四链体荧光特性的猪瘟病毒检测方法及试剂盒 |
CN110452965A (zh) * | 2019-05-28 | 2019-11-15 | 临沂大学 | 基于重组酶扩增和g-四连体的层出镰刀菌目视检测方法 |
CN112048547A (zh) * | 2019-06-06 | 2020-12-08 | 同济大学 | 一种脊肌萎缩症致病基因检测试剂盒及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102041317B (zh) | 2013-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tsai et al. | Development of a loop-mediated isothermal amplification for rapid detection of orf virus | |
Liu et al. | A direct isothermal amplification system adapted for rapid SNP genotyping of multifarious sample types | |
CN111321249A (zh) | 一种SARS-CoV-2的环介导等温扩增检测引物组、试剂盒及方法 | |
US20180073087A1 (en) | Qualitative and absolute quantification kit for detecting hepatitis b virus cccdna | |
GB2607805A (en) | Novel coronavirus detection reagent and detection method | |
CN102041317B (zh) | 检测猪瘟病毒的试剂 | |
WO2022257663A1 (zh) | 一种检测筛查新冠病毒n501y突变的方法及试剂盒 | |
CN103525911A (zh) | 利用高分辨熔解曲线分析技术检测华法林个体化用药相关基因多态性的方法 | |
CN103045754B (zh) | 一步法检测z/s亚型埃博拉病毒的实时荧光定量rt‑pcr方法及其试剂盒 | |
CN102041318B (zh) | 基于g4dna酶显色的可视化基因检测猪瘟病毒的试剂 | |
CN101182585B (zh) | 一种鉴别hbv基因突变类型的方法及其专用芯片与试剂盒 | |
Lu et al. | Rapid and highly specific detection of communicable pathogens using one-pot loop probe-mediated isothermal amplification (oLAMP) | |
Tian et al. | dsDNA/ssDNA-switchable isothermal colorimetric biosensor based on a universal primer and λ exonuclease | |
RU2385943C2 (ru) | Олигонуклеотидные праймеры, способ и тест-система для выявления генома вируса блютанга методом полимеразной цепной реакции в формате электрофоретической детекции продуктов амплификации | |
ES2573405T3 (es) | Detección de bacterias y hongos | |
Ozoemena et al. | Comparative evaluation of measles virus specific TaqMan PCR and conventional PCR using synthetic and natural RNA templates | |
CN108603226A (zh) | 乙型肝炎病毒cccdna的定量测量 | |
Ihira et al. | Loop-mediated isothermal amplification for discriminating between human herpesvirus 6 A and B | |
CN114350854B (zh) | 一种基于RAA-CRISPR检测SARS-CoV-2 69-70del位点的方法 | |
ES2850324T3 (es) | Método de detección de hemoplasmas | |
KR101655069B1 (ko) | 잉어 허피스 바이러스 그레이 에스피에이치 판별용 유전자 마커, 및 이를 이용한 원인바이러스의 판별 방법 | |
KR101655071B1 (ko) | 참돔 이리도 바이러스 판별용 유전자 마커, 및 이를 이용한 원인바이러스의 판별 방법 | |
KR101655068B1 (ko) | 잉어 허피스 바이러스 베르코이버 티케이 판별용 유전자 마커, 및 이를 이용한 원인바이러스의 판별 방법 | |
Wang et al. | Visual and label-free ASFV and PCV2 detection by CRISPR-Cas12a combined with G-quadruplex | |
JP5315519B2 (ja) | コイヘルペスウイルス(khv)の検出方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: Two Beijiao village, Chongyang Town, Sichuan City, Chengdu Province, China (611200), Applicant after: Chengdu Juxing Agriculture and Animal Husbandry Technology Co., Ltd. Applicant after: Wang Yi Address before: Two Beijiao village, Chongyang Town, Sichuan City, Chengdu Province, China (611200), Applicant before: Chengdu Giastar Pig Industry Co., Ltd. Applicant before: Wang Yi |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: CHENGDU GIASTAR PIG INDUSTRY CO., LTD. TO: CHENGDU GIASTAR AGRICULTURE AND PASTURE TECHNOLOGY CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: Two Beijiao village, Chongyang street, Sichuan City, Chengdu Province, China (611200), Patentee after: Superstar Limited by Share Ltd Patentee after: Wang Yi Address before: Two Beijiao village, Chongyang Town, Sichuan City, Chengdu Province, China (611200), Patentee before: Chengdu Juxing Agriculture and Animal Husbandry Technology Co., Ltd. Patentee before: Wang Yi |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No.208, tomorrow Avenue, Chongyang street, Chongzhou City, Chengdu City, Sichuan Province Patentee after: Giant star agriculture and animal husbandry Co., Ltd Patentee after: Wang Yi Address before: Two Beijiao village, Chongyang street, Sichuan City, Chengdu Province, China (611200), Patentee before: Superstar Limited by Share Ltd. Patentee before: Wang Yi |